AGP Executive Report
Last update: an hour agoPatient Safety: Doctors warn that teenage boys are taking the bladder-cancer drug erdafitinib in a social-media-fueled bid to grow taller; it is not approved for children and can pose serious risks. Rural Access: Iowa will receive $216 million in the second year of a federal rural-health program, as states face major Medicaid funding cuts. Children’s Care: A study of 71,451 pediatric surgeries found that children traveling more than 60 miles had higher odds of complications, longer stays and higher hospital charges. Healthcare AI: Wearable maker Oura plans to buy AI primary-care company Counsel Health for $625 million; a Dubai hospital has also introduced AI support for chest X-rays and brain scans. Alzheimer’s Research: A genetic study of 2.8 million people identified 127 DNA regions linked to Alzheimer’s risk, including 48 not previously mapped in this context. Epilepsy Treatment: Children’s Hospital Los Angeles reports early results from thalamic responsive neurostimulation in 10 children, with seizures reduced by an average of 80% to 85%.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.